Cargando…
Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease
Castleman disease (CD) is a rare lymphoproliferative disorder. The mechanistic target of rapamycin (mTOR) pathway is a key regulator of various cellular functions, which may be related with the potential mechanisms of CD occurrence. We retrospectively collected the clinical information of 60 CD pati...
Autores principales: | Qian, Siyu, Ding, Mengjie, Hou, Huting, Wang, Zeyuan, Zhang, Jieming, Zhang, Yue, Dong, Meng, Zhu, Linan, Wang, Guannan, Li, Wencai, Zhang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152317/ https://www.ncbi.nlm.nih.gov/pubmed/35655778 http://dx.doi.org/10.3389/fimmu.2022.899073 |
Ejemplares similares
-
The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
por: Ge, Jingjing, et al.
Publicado: (2022) -
Recurrent PDGFRB mutations in unicentric Castleman disease
por: Li, Zhaoming, et al.
Publicado: (2019) -
Castleman Disease in a Patient with Common Variable Immunodeficiency
por: Ricciardi, Luisa, et al.
Publicado: (2019) -
The CARD8 T60 variant associates with NLRP1 and negatively regulates its activation
por: Xu, Zhihao, et al.
Publicado: (2022) -
Multicentric Castleman’s disease in human immunodeficiency virus infection: two case reports
por: Caroline Ribeiro Sales, Amanda, et al.
Publicado: (2018)